✨ Free AI Report
HeartSciences Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research HeartSciences Inc.
Company Research

HeartSciences Inc.: Business Overview, Financials & Competitive Analysis

HeartSciences Inc. scores 3/10 on the AskCyborg Cyborg Score (Weak). Speculative AI-driven medical device play with high revenue growth potential but substantial profitability and regulatory hurdles ahead. The company currently has negative EPS of -$6.88 with analyst forecasts predicting continued losses of -$3.80 for 2026. Despite forecast revenue growth of 488.3%, the company remains pre-profitability with minimal scale and faces.

What is HeartSciences Inc.'s industry? HeartSciences Inc. (heartsciences.com) operates in Medical Device / Healthcare Information Technology - AI-Enhanced Cardiac Diagnostics. AskCyborg classifies HeartSciences Inc. under Medical Device / Healthcare Information Technology - AI-Enhanced Cardiac Diagnostics in its company registry.

HeartSciences is an AI-powered medical technology company that applies artificial intelligence to electrocardiography (ECG) to expand clinical usefulness. The company develops AI-ECG solutions including the MyoVista w...

3/ 10Weak

Cyborg Score thesis

Speculative AI-driven medical device play with high revenue growth potential but substantial profitability and regulatory hurdles...

Read the full analyst-debate transcript →
Industry Medical Device / Healthcare Information Technology - AI-Enhanced Cardiac Diagnostics
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 16, 2026
AI-Generated Research
30+ Page Report

Get the Latest HeartSciences Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for HeartSciences Inc.

AskCyborg analysts argue the bull and bear cases for HeartSciences Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
HeartSciences Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

HeartSciences Inc. Overview

Pro stress-test →

HeartSciences is an AI-powered medical technology company that applies artificial intelligence to electrocardiography (ECG) to expand clinical usefulness. The company develops AI-ECG solutions including the MyoVista wavECG device and MyoVista Insights cloud-based platform, targeting earlier cardiac disease detection in point-of-care clinical settings.

Strategic Profile

Pro stress-test →

The company focuses on making ECG a more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. With a micro-cap valuation and early-stage commercial traction, HeartSciences is positioned as a pre-revenue growth play betting on AI-enhanced cardiac diagnostics adoption.

Competitive Landscape

Pro stress-test →

HeartSciences operates in the AI-enhanced ECG/cardiac diagnostic space, competing with established medical device manufacturers (GE Healthcare, Philips, Medtronic) that have AI initiatives, as well as emerging cardiac AI startups. The company's differentiation rests on its specialized MyoVista platform and cloud-agnostic architecture, though commercial traction remains limited relative to incumbents.

Industry Context

HeartSciences Inc. operates in Medical Device / Healthcare Information Technology - AI-Enhanced Cardiac Diagnostics.

Key facts

Founded: 2007 · Headquarters: Southlake, Texas, US · Employees: 15 · Revenue: Minimal/Pre-commercial stage · Market cap: $8.91M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on HeartSciences Inc..

  • Company rebranded from Heart Test Laboratories to HeartSciences Inc. in October 2024, signaling shift toward broader AI-ECG platform positioning
  • FDA 510(k) submission announced for MyoVista wavECG in December 2025, representing critical regulatory milestone
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Business updates and investor communications enhancements
  • December 2025FDA 510(k) submission for MyoVista wavECG device
  • +2 moreTrack every material event for HeartSciences Inc. as it happens. Explore monitoring →
Get alerted when HeartSciences Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare HeartSciences Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

HeartSciences Inc. operates in Medical Device / Healthcare Information Technology - AI-Enhanced Cardiac Diagnostics. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Device / Healthcare Information Technology - AI-Enhanced Cardiac Diagnostics research →
NEW · MCP server

Ask your AI assistant about HeartSciences Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare HeartSciences Inc. and its top competitor on Cyborg Score”
“What did HeartSciences Inc. do this quarter?”
“Is HeartSciences Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does HeartSciences Inc. do?+
HeartSciences is an AI-powered medical technology company that applies artificial intelligence to electrocardiography (ECG) to expand clinical usefulness. The company develops AI-ECG solutions including the MyoVista w...
What is HeartSciences Inc.'s Cyborg Score?+
HeartSciences Inc. has a Cyborg Score of 3/10 (Weak). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are HeartSciences Inc.'s main competitors?+
Named competitors include AI-Enhanced Cardiac Monitoring, Philips CardiacPoint, Medtronic Cardiac AI Solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full HeartSciences Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the HeartSciences Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track HeartSciences Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual